Aug 21, 2018
Smac mimetics are a new class of targeted drugs being developed for the treatment of solid tumours and hematologic cancers. Smac mimetics specifically induce apoptotic cancer cell death and block pro-survival signalling in cancer cells.
This episode provides an overview of the biology of Smac, an endogenous pro-apoptotic molecule, and the development of Smac mimetics as a novel therapeutic approach to treat cancer.
This article was written by Dr Mark A. McKinlay
If you'd like to view the original article then follow the link below:
For more information on Drug Discovery World, head to: